Inhalation Drug Products for ''Safety Thresholds and Best Practices'' Recommendations Perspectives on the PQRI Extractables and Leachables

نویسندگان

  • Daniel L. Norwood
  • Lee M. Nagao
  • Cheryl L. M. Stults
  • DANIEL L. NORWOOD
  • LEE M. NAGAO
  • CHERYL L. M. STULTS
چکیده

In 2006, the Product Quality Research Institute’s (PQRI) Leachables and Extractables Working Group released a comprehensive and detailed recommendation document related to leachables and extractables for inhalation drug products. The document includes best pharmaceutical development practice recommendations regarding container closure/delivery system component composition and selection, controlled extraction studies, drug product leachables studies, and routine extractables testing for component release. Also included in the document are two safety-based thresholds for leachables in inhalation drug products, the qualification threshold (QT) and the safety concern threshold (SCT), the first such safety-based thresholds for leachables in any drug product type. A process was described for converting the SCT into an analytically useful threshold for leachables/extractables characterization, the analytical evaluation threshold (AET), with consideration of individual drug product dosing parameters and container closure system component characteristics. This commentary presents the history and evolution of this recommendation document starting from the propellant changeover (chlorofluorocarbons to hydrofluorocarbons) in metered dose inhaler drug products, which helped prompt interest in inhalation drug product leachables, through the work process of the PQRI group. The overall positive acceptance of the PQRI recommendations is discussed, along with a brief summary of regulatory initiatives influenced by the recommendations. Also presented and discussed are certain key issues and questions that have arisen since the recommendation document was released. The extension and application of best practice recommendations to other high risk drug product types (e.g., large and small volume parenterals, ophthalmics), led by the PQRI Parenteral and Ophthalmic Drug Product Working Group, is introduced and considered.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.

Safety thresholds for chemical impurities and leachables in consumer products such as foods and drugs have helped to ensure public health while establishing scientifically sound limits for identification and risk assessment of these compounds. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group, a collaboration of chemists and toxicologists from the U.S. Food...

متن کامل

Determination of hexane impurities in eye drops solutions utilizing HS-GC/FID

The potential deleterious effects of extractables/leachables in pharmaceutical products led the USP, EP and JP to require extractable and toxicity testing of container/closure systems. To that, a HS-GC/FID method was developed and validated for the determination of hexane as potential extractable residue from pharmaceutical container closure system into eye drops solutions. A migration study wa...

متن کامل

The Importance of Extractables & Leachables Testing for Injectable Drug Delivery Systems

Copyright © 2009 ONdrugDelivery Publishing Ltd 22 Suppliers of pharmaceutical packaging components and delivery devices have been working closely with the industry in an effort to provide solutions for mitigating the risk associated with extractables and leachables. This effort includes managing both the technical and regulatory aspects of the subject. The following example illustrates the chal...

متن کامل

Analysis of Extractables and Leachables

Manufacturers of pharmaceuticals, drug delivery systems, and biomedical devices have come under growing pressure to perform sensitive and accurate analytical studies to detect, identify, and quantify extractable and leachable compounds (E&Ls). E&Ls may be inherently toxic or may contaminate or interact with drug products, posing a potential danger to patients. Even as regulatory guidance relate...

متن کامل

Determination of Extractables, Leachables, Residual Solvents, and Unknowns by Mass Spectrometry

www.pharmtech.com he pharmaceutical industry is coming under increasing pressure to identify, quantify, and monitor impurities. Potential sources of these impurities include residual solvents or other chemicals used during the manufacturing process as well as degradants of the drug substance or excipients. FDA also is focusing on compounds extracted from packaging material and leachables from t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013